Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

A standardized clinical algorithm for patient selection in cellular therapy across nineteen solid and hematological malignancies: An algorithm development study

Cellular therapies—chimeric antigen receptor T-cell (CAR-T), tumor-infiltrating lymphocyte (TIL), T-cell receptor (TCR)-engineered, gamma-delta (γδ) T-cell, and high-dose interleukin-2—have transformed the management of refractory malignancies. Over 6,000 interventional cell therapy trials are registered globally...

Atanu Bhattacharjee, V. Patil, R. Kothari et al. · 0 citations
Review Open access 2026

PD-1 Inhibition and the Changing Frontline Landscape of Advanced Classical Hodgkin Lymphoma: A Narrative Review with a Focus on Applicability in Lower- and Middle-Income Settings

Frontline management of advanced-stage classical Hodgkin lymphoma (cHL) has been transformed by PET adapted therapy, brentuximab vedotin (BV)-based regimens, and PD-1 blockade; however, drug cost and infrastructure barriers constrain translation to lower- and middle-income countries (LMICs). We conducted a narrative re...

A. Jain, Punam Rabha, J. Wisely et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.